chr3-4683555-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378452.1(ITPR1):​c.3327+4G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00583 in 1,613,760 control chromosomes in the GnomAD database, including 289 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0084 ( 37 hom., cov: 33)
Exomes 𝑓: 0.0056 ( 252 hom. )

Consequence

ITPR1
NM_001378452.1 splice_region, intron

Scores

2
Splicing: ADA: 0.0002047
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.204

Publications

5 publications found
Variant links:
Genes affected
ITPR1 (HGNC:6180): (inositol 1,4,5-trisphosphate receptor type 1) This gene encodes an intracellular receptor for inositol 1,4,5-trisphosphate. Upon stimulation by inositol 1,4,5-trisphosphate, this receptor mediates calcium release from the endoplasmic reticulum. Mutations in this gene cause spinocerebellar ataxia type 15, a disease associated with an heterogeneous group of cerebellar disorders. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
ITPR1 Gene-Disease associations (from GenCC):
  • aniridia-cerebellar ataxia-intellectual disability syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • spinocerebellar ataxia type 29
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet
  • spinocerebellar ataxia type 15/16
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 3-4683555-G-A is Benign according to our data. Variant chr3-4683555-G-A is described in ClinVar as Benign. ClinVar VariationId is 345724.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0616 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITPR1NM_001378452.1 linkc.3327+4G>A splice_region_variant, intron_variant Intron 27 of 61 ENST00000649015.2 NP_001365381.1
ITPR1NM_001168272.2 linkc.3282+4G>A splice_region_variant, intron_variant Intron 26 of 60 NP_001161744.1 Q14643-2
ITPR1NM_001099952.4 linkc.3300+4G>A splice_region_variant, intron_variant Intron 27 of 58 NP_001093422.2 Q14643-3B4DER3Q59H91
ITPR1NM_002222.7 linkc.3255+4G>A splice_region_variant, intron_variant Intron 26 of 57 NP_002213.5 Q14643-4B4DER3B4DGH1Q59H91

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITPR1ENST00000649015.2 linkc.3327+4G>A splice_region_variant, intron_variant Intron 27 of 61 NM_001378452.1 ENSP00000497605.1 Q14643-1
ITPR1ENST00000354582.12 linkc.3300+4G>A splice_region_variant, intron_variant Intron 27 of 61 5 ENSP00000346595.8 A0A3F2YNW8
ITPR1ENST00000648266.1 linkc.3300+4G>A splice_region_variant, intron_variant Intron 27 of 61 ENSP00000498014.1 A0A3B3IU04
ITPR1ENST00000650294.1 linkc.3282+4G>A splice_region_variant, intron_variant Intron 26 of 60 ENSP00000498056.1 A0A3B3ITU8
ITPR1ENST00000443694.5 linkc.3282+4G>A splice_region_variant, intron_variant Intron 26 of 60 1 ENSP00000401671.2 Q14643-2
ITPR1ENST00000648309.1 linkc.3255+4G>A splice_region_variant, intron_variant Intron 24 of 58 ENSP00000497026.1 Q14643-5
ITPR1ENST00000357086.10 linkc.3300+4G>A splice_region_variant, intron_variant Intron 27 of 58 1 ENSP00000349597.4 Q14643-3
ITPR1ENST00000456211.8 linkc.3255+4G>A splice_region_variant, intron_variant Intron 26 of 57 1 ENSP00000397885.2 Q14643-4
ITPR1ENST00000648038.1 linkc.1137+4G>A splice_region_variant, intron_variant Intron 8 of 41 ENSP00000497872.1 A0A3B3ITQ1
ITPR1ENST00000648431.1 linkc.627+4G>A splice_region_variant, intron_variant Intron 5 of 38 ENSP00000498149.1 A0A3B3IU05
ITPR1ENST00000648212.1 linkc.234+4G>A splice_region_variant, intron_variant Intron 3 of 38 ENSP00000498022.1 A0A3B3IU13

Frequencies

GnomAD3 genomes
AF:
0.00838
AC:
1276
AN:
152236
Hom.:
37
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00893
Gnomad EAS
AF:
0.0675
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.0681
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00179
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.0124
AC:
3083
AN:
248984
AF XY:
0.0113
show subpopulations
Gnomad AFR exome
AF:
0.000452
Gnomad AMR exome
AF:
0.000493
Gnomad ASJ exome
AF:
0.00815
Gnomad EAS exome
AF:
0.0697
Gnomad FIN exome
AF:
0.0637
Gnomad NFE exome
AF:
0.00212
Gnomad OTH exome
AF:
0.0117
GnomAD4 exome
AF:
0.00556
AC:
8131
AN:
1461406
Hom.:
252
Cov.:
32
AF XY:
0.00542
AC XY:
3937
AN XY:
726912
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33474
American (AMR)
AF:
0.000492
AC:
22
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00800
AC:
209
AN:
26132
East Asian (EAS)
AF:
0.0854
AC:
3391
AN:
39690
South Asian (SAS)
AF:
0.00172
AC:
148
AN:
86250
European-Finnish (FIN)
AF:
0.0604
AC:
3223
AN:
53396
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.000682
AC:
758
AN:
1111606
Other (OTH)
AF:
0.00611
AC:
369
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
498
997
1495
1994
2492
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00836
AC:
1274
AN:
152354
Hom.:
37
Cov.:
33
AF XY:
0.0116
AC XY:
863
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.000553
AC:
23
AN:
41584
American (AMR)
AF:
0.000523
AC:
8
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00893
AC:
31
AN:
3470
East Asian (EAS)
AF:
0.0675
AC:
350
AN:
5188
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4828
European-Finnish (FIN)
AF:
0.0681
AC:
723
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00179
AC:
122
AN:
68040
Other (OTH)
AF:
0.00473
AC:
10
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
60
120
180
240
300
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00231
Hom.:
3
Bravo
AF:
0.00390
Asia WGS
AF:
0.0240
AC:
85
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Mar 06, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Sep 02, 2016
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant cerebellar ataxia Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
16
DANN
Benign
0.27
PhyloP100
-0.20
Mutation Taster
=87/13
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00020
dbscSNV1_RF
Benign
0.030
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2306878; hg19: chr3-4725239; COSMIC: COSV56973923; API